Similar articles for PMID: 29108384

Year	Number of Results
1933	1
1991	1
1994	1
1995	2
1996	3
1997	2
1998	2
1999	2
2001	1
2002	1
2005	3
2006	3
2007	4
2008	1
2011	2
2012	3
2013	3
2014	1
2015	6
2016	3
2017	2
2018	2
2019	2
2020	1
2021	3
2022	2
2023	1
2024	0

1

Efficacy, safety and proper dose analysis of PEGylated granulocyte colony-stimulating factor as support for dose-dense adjuvant chemotherapy in node positive Chinese breast cancer patients.

Zhang F, LingHu R, Zhan X, Li R, Feng F, Gao X, Zhao L, Yang J. Zhang F, et al. Oncotarget. 2017 May 24;8(45):80020-80028. doi: 10.18632/oncotarget.18145. eCollection 2017 Oct 3. Oncotarget. 2017. PMID: 29108384 Free PMC article.

2

[The role of prophylactic use of pegylated recombinant human granulocyte colony-stimulating factor(PEG-rhG-CSF) in breast cancer receiving adjuvant chemotherapy].

Zhang JY, Liu YX, Wang H, Mi L, Song GH, Jiang HF, Yan Y, Shao B, Kong WY, Zhang RY, Ran R, Liu XR, Wang J, Lin YT, Li HP. Zhang JY, et al. Zhonghua Yi Xue Za Zhi. 2018 Sep 11;98(34):2718-2721. doi: 10.3760/cma.j.issn.0376-2491.2018.34.008. Zhonghua Yi Xue Za Zhi. 2018. PMID: 30220167 Chinese.

3

The use of granulocyte colony stimulating factor (G-CSF) and management of chemotherapy delivery during adjuvant treatment for early-stage breast cancer--further observations from the IMPACT solid study.

Mäenpää J, Varthalitis I, Erdkamp F, Trojan A, Krzemieniecki K, Lindman H, Bendall K, Vogl FD, Verma S. Mäenpää J, et al. Breast. 2016 Feb;25:27-33. doi: 10.1016/j.breast.2015.11.007. Epub 2015 Dec 20. Breast. 2016. PMID: 26801413

4

Five-day course of granulocyte colony-stimulating factor in patients with prolonged neutropenia after adjuvant chemotherapy for breast cancer is a safe and cost-effective schedule to maintain dose-intensity.

Ribas A, Albanell J, Bellmunt J, Solé-Calvo LA, Bermejo B, Gallardo E, Vidal R, Vera R, Eres N, Carulla J, Baselga J. Ribas A, et al. J Clin Oncol. 1996 May;14(5):1573-80. doi: 10.1200/JCO.1996.14.5.1573. J Clin Oncol. 1996. PMID: 8622074 Clinical Trial.

5

Acute hematologic feasibility of G-CSF supported dose-escalated FEC therapy as adjuvant treatment after breast cancer surgery.

Ottosson S, Magnusson K, Hultborn R. Ottosson S, et al. Anticancer Res. 1999 Sep-Oct;19(5C):4429-34. Anticancer Res. 1999. PMID: 10650787

6

[Efficacy of once-per-cycle administration pegylated recombinant human granulocyte colony-stimulating factor in chemotherapy-induced neutropenia in a phase I trial].

Yang S, Shi YK, Liu P, Han XH, He XH, Cai YM, Chen ZM. Yang S, et al. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2006 Jun;28(3):339-44. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2006. PMID: 16900629 Clinical Trial. Chinese.

7

[Safety of adjuvant dose-dense chemotherapy with paclitaxel and epirubicin for high-risk breast cancer].

Wu WH, Li Q, Xu BH, Zhang P, Zhao LM, Yuan P, Wang JY, Cai RG, Zhou AP. Wu WH, et al. Zhonghua Zhong Liu Za Zhi. 2008 Jul;30(7):548-51. Zhonghua Zhong Liu Za Zhi. 2008. PMID: 19062727 Clinical Trial. Chinese.

8

Frequency of febrile neutropenia in breast cancer patients receiving epirubicin and docetaxel/paclitaxel with colony-stimulating growth factors: a comparison of filgrastim or lenograstim with pegfilgrastim.

Schippinger W, Holub R, Dandachi N, Bauernhofer T, Samonigg H. Schippinger W, et al. Oncology. 2006;70(4):290-3. doi: 10.1159/000094890. Epub 2006 Aug 4. Oncology. 2006. PMID: 16899982

9

Comparison of the effects of pegylated granulocyte-colony stimulating factor and granulocyte-colony stimulating factor on cytopenia induced by dose-dense chemotherapy in breast cancer patients.

Ashrafi F, Salmasi M. Ashrafi F, et al. J Res Med Sci. 2018 Aug 23;23:73. doi: 10.4103/jrms.JRMS_463_17. eCollection 2018. J Res Med Sci. 2018. PMID: 30181755 Free PMC article.

10

Phase III trial comparing granulocyte colony-stimulating factor to leridistim in the prevention of neutropenic complications in breast cancer patients treated with docetaxel/doxorubicin/cyclophosphamide: results of the BCIRG 004 trial.

Nabholtz JM, Cantin J, Chang J, Guevin R, Patel R, Tkaczuk K, Vodvarka P, Lindsay MA, Reese D, Riva A, Mackey J. Nabholtz JM, et al. Clin Breast Cancer. 2002 Oct;3(4):268-75. doi: 10.3816/CBC.2002.n.030. Clin Breast Cancer. 2002. PMID: 12425755 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

55 results

Results by year